Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenjirou Higashi

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Molecular Pharmaceutics|March 20, 2023
Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 1: Effects of Polymer and Drug ChiralitiesKeisuke Ueda, Kenjirou Higashi, Kunikazu Moribe
Nano Letters|July 13, 2022
Multistep Crystallization of Pharmaceutical Amorphous Nanoparticles via a Cognate Pathway of Oriented Attachment: Direct Evidence of Nonclassical Crystallization for Organic MoleculesZiqiao Chen, Kenjirou Higashi, Keisuke Ueda, et al.
International Journal of Pharmaceutics|August 9, 2015
The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rateKenjirou Higashi, Hiroki Hayashi, Keiji Yamamoto, et al.
International Journal of Pharmaceutics|March 21, 2021
Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silicaArif Budiman, Kenjirou Higashi, Keisuke Ueda, et al.
Molecular Pharmaceutics|April 8, 2015
Direct evaluation of molecular States of piroxicam/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopiesYuki Hasegawa, Kenjirou Higashi, Keiji Yamamoto, et al.
International Journal of Pharmaceutics|January 21, 2014
The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvementKeisuke Ueda, Kenjirou Higashi, Keiji Yamamoto, et al.
Journal of Pharmaceutical Sciences|June 28, 2024
Impact of colloidal drug-rich droplet size and amorphous solubility on drug membrane permeability: A comprehensive analysisKeisuke Ueda, Shiryu Takemoto, Kenjirou Higashi, et al.
Journal of Drug Delivery|May 24, 2011
Drug nanoparticle formulation using ascorbic Acid derivativesKunikazu Moribe, Waree Limwikrant, Kenjirou Higashi, et al.
International Journal of Pharmaceutics|August 14, 2021
Revealing the mechanism of morphological variation of amorphous drug nanoparticles formed by aqueous dispersion of ternary solid dispersionZhijing Zhao, Kenjirou Higashi, Keisuke Ueda, et al.
Chemical & Pharmaceutical Bulletin|January 22, 2025
Preparation of a Stable Indomethacin Supersaturated Solution Using Hydrophobically Modified Hydroxypropylmethylcellulose and α-CyclodextrinHiroki Akahoshi, Fumitoshi Hirayama, Kenjirou Higashi, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Molecular Pharmaceutics|March 20, 2023
Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 1: Effects of Polymer and Drug ChiralitiesKeisuke Ueda, Kenjirou Higashi, Kunikazu Moribe
Nano Letters|July 13, 2022
Multistep Crystallization of Pharmaceutical Amorphous Nanoparticles via a Cognate Pathway of Oriented Attachment: Direct Evidence of Nonclassical Crystallization for Organic MoleculesZiqiao Chen, Kenjirou Higashi, Keisuke Ueda, et al.
International Journal of Pharmaceutics|August 9, 2015
The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rateKenjirou Higashi, Hiroki Hayashi, Keiji Yamamoto, et al.
International Journal of Pharmaceutics|March 21, 2021
Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silicaArif Budiman, Kenjirou Higashi, Keisuke Ueda, et al.
Molecular Pharmaceutics|April 8, 2015
Direct evaluation of molecular States of piroxicam/poloxamer nanosuspension by suspended-state NMR and Raman spectroscopiesYuki Hasegawa, Kenjirou Higashi, Keiji Yamamoto, et al.
International Journal of Pharmaceutics|January 21, 2014
The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvementKeisuke Ueda, Kenjirou Higashi, Keiji Yamamoto, et al.
Journal of Pharmaceutical Sciences|June 28, 2024
Impact of colloidal drug-rich droplet size and amorphous solubility on drug membrane permeability: A comprehensive analysisKeisuke Ueda, Shiryu Takemoto, Kenjirou Higashi, et al.
Journal of Drug Delivery|May 24, 2011
Drug nanoparticle formulation using ascorbic Acid derivativesKunikazu Moribe, Waree Limwikrant, Kenjirou Higashi, et al.
International Journal of Pharmaceutics|August 14, 2021
Revealing the mechanism of morphological variation of amorphous drug nanoparticles formed by aqueous dispersion of ternary solid dispersionZhijing Zhao, Kenjirou Higashi, Keisuke Ueda, et al.
Chemical & Pharmaceutical Bulletin|January 22, 2025
Preparation of a Stable Indomethacin Supersaturated Solution Using Hydrophobically Modified Hydroxypropylmethylcellulose and α-CyclodextrinHiroki Akahoshi, Fumitoshi Hirayama, Kenjirou Higashi, et al.
Pageof 14